{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:22:06Z","timestamp":1791602526659,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006444","name":"Center for Excellence in Regulatory Science and Innovation, University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["U01 FD005946"],"award-info":[{"award-number":["U01 FD005946"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.vascn.2024.107562","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:46:43Z","timestamp":1727300803000},"page":"107562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Inhibition of hERG K channels by verapamil at physiological temperature: Implications for the CiPA initiative"],"prefix":"10.1016","volume":"130","author":[{"given":"Ashley A.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Trudeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2024.107562_bb0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.str.2020.12.007","article-title":"Cryo-EM structure of K(+)-bound hERG channel complexed with the blocker astemizole","volume":"29","author":"Asai","year":"2021","journal-title":"Structure"},{"key":"10.1016\/j.vascn.2024.107562_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057115594589","article-title":"A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm","volume":"21","author":"Fermini","year":"2016","journal-title":"Journal of Biomolecular Screening"},{"key":"10.1016\/j.vascn.2024.107562_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2015.34","article-title":"Evolution of strategies to improve preclinical cardiac safety testing","volume":"15","author":"Gintant","year":"2016","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.vascn.2024.107562_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bar017","article-title":"hERGAPDbase: A database documenting hERG channel inhibitory potentials and APD-prolongation activities of chemical compounds","volume":"2011","author":"Hishigaki","year":"2011","journal-title":"Database: The Journal of Biological Databases and Curation"},{"key":"10.1016\/j.vascn.2024.107562_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2017.04.002","article-title":"Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative","volume":"87","author":"Huang","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107562_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vascn.2017.04.002","article-title":"Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative","volume":"87","author":"Huang","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"9","key":"10.1016\/j.vascn.2024.107562_bb2020","doi-asserted-by":"crossref","first-page":"102233","DOI":"10.1016\/j.jbc.2022.102233","article-title":"The N-linker region of hERG1a upregulates hERG1b potassium channels","volume":"298","author":"Johnson","year":"2022","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.vascn.2024.107562_bb2015","doi-asserted-by":"crossref","first-page":"jcs206730","DOI":"10.1242\/jcs.206730","article-title":"Localization and functional consequences of a direct interaction between TRIOBP-1 and hERG proteins in the heart","volume":"131","author":"Jones","year":"2018","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.vascn.2024.107562_bb0035","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1073\/pnas.1414945111","article-title":"hERG 1b is critical for human cardiac repolarization","volume":"111","author":"Jones","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2024.107562_bb0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0092-8674(01)00243-4","article-title":"Molecular and cellular mechanisms of cardiac arrhythmias","volume":"104","author":"Keating","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.vascn.2024.107562_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2004.06.003","article-title":"Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus pattern","volume":"50","author":"Kirsch","year":"2004","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107562_bb0050","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: Superior to the HERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Scientific Reports"},{"issue":"52","key":"10.1016\/j.vascn.2024.107562_bb2010","doi-asserted-by":"crossref","first-page":"21548","DOI":"10.1074\/jbc.M117.816488","article-title":"hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels","volume":"292","author":"McNally","year":"2017","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.vascn.2024.107562_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.vascn.2010.02.007","article-title":"Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 \u00b0C: Cisapride versus dofetilide","volume":"61","author":"Milnes","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107562_bb0060","doi-asserted-by":"crossref","first-page":"12329","DOI":"10.1073\/pnas.210244497","article-title":"A structural basis for drug-induced long QT syndrome","volume":"97","author":"Mitcheson","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2024.107562_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.vascn.2024.107562_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/clc.4960160910","article-title":"Torsade de pointes","volume":"16","author":"Roden","year":"1993","journal-title":"Clinical Cardiology"},{"key":"10.1016\/j.vascn.2024.107562_bb0075","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1016\/j.vascn.2024.107562_bb0080","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1161\/CIRCRESAHA.108.185249","article-title":"Physiological properties of hERG 1a\/1b heteromeric currents and a hERG 1b-specific mutation associated with long-QT syndrome","volume":"103","author":"Sale","year":"2008","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107562_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.vascn.2024.107562_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1085\/jgp.96.1.195","article-title":"Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents","volume":"96","author":"Sanguinetti","year":"1990","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/j.vascn.2024.107562_bb0095","first-page":"H393","article-title":"Delayed rectifier outward K+ current is composed of two currents in guinea pig atrial cells","volume":"260","author":"Sanguinetti","year":"1991","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.vascn.2024.107562_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241362","article-title":"Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block","volume":"15","author":"Tran","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vascn.2024.107562_bb2005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1085\/jgp.201110683","article-title":"hERG1a N-terminal eag domain containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a\/hERG1b channels: A possible mechanism for Long QT syndrome","volume":"138","author":"Trudeau","year":"2011","journal-title":"Journal of General Physiology"},{"key":"10.1016\/j.vascn.2024.107562_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","article-title":"HERG, a human inward rectifier in the voltage-gated potassium channel family","volume":"269","author":"Trudeau","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.vascn.2024.107562_bb0110","first-page":"61134","article-title":"International conference on harmonisation; guidance on E14 clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs","volume":"70","author":"U.S. Food and Drug Administration, H","year":"2005","journal-title":"Federal Registry"},{"key":"10.1016\/j.vascn.2024.107562_bb0115","series-title":"E14 and S7B clinical and nonclinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential-questions and answers: Guidance for industry","author":"U.S. Food and Drug Administration, H","year":"2022"},{"issue":"1","key":"10.1016\/j.vascn.2024.107562_bb2000","doi-asserted-by":"crossref","first-page":"C165","DOI":"10.1152\/ajpcell.00596.2005","article-title":"Temperature dependence of human ether-a-go-go-related gene K+ currents","volume":"291","author":"Vandenberg","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.vascn.2024.107562_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2018.06.005","article-title":"CiPA challenges and opportunities from a non-clinical, clinical and regulatory perspectives. An overview of the safety pharmacology scientific discussion","volume":"93","author":"Wallis","year":"2018","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107562_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.vascn.2017.02.017","article-title":"Measuring kinetics and potency of hERG block for CiPA","volume":"87","author":"Windley","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107562_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2022.107192","article-title":"High throughput measurement of hERG drug block kinetics using the CiPA dynamic protocol","volume":"117","author":"Windley","year":"2022","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107562_bb0135","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.RES.84.9.989","article-title":"Mechanism of block and identification of the verapamil binding domain to HERG potassium channels","volume":"84","author":"Zhang","year":"1999","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107562_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-3495(98)77782-3","article-title":"Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature","volume":"74","author":"Zhou","year":"1998","journal-title":"Biophysical Journal"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871924000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T22:36:21Z","timestamp":1734474981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871924000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"alternative-id":["S1056871924000728"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107562","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.12.571313","asserted-by":"object"}]},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of hERG K channels by verapamil at physiological temperature: Implications for the CiPA initiative","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107562"}}